Filipa C. Gouveia - Publications

Therapeutic potential of phytocannabinoids in depression and cognitive dysfunction: Evidence from preclinical models.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 17, 2026

Protective effects of irbesartan against neurodegeneration in APP/PS1 mice: Unraveling its triple anti-apoptotic, anti-inflammatory and anti-oxidant action.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 19, 2025

Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan.

Journal: Biochemical pharmacology

Published: May 27, 2024

Arthrogryposis Multiplex Congenita and the Importance of Orthoses: A Case Report.

Journal: Cureus

Published: February 09, 2024

Intrathecal baclofen for the management of hereditary spastic paraparesis: a systematic review.

Journal: International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation

Published: January 22, 2024

Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model.

Journal: International immunopharmacology

Published: September 26, 2023

Post-stroke dysphagia: Clinical characteristics and evolution in a single-primary stroke center.

Journal: NeuroRehabilitation

Published: February 22, 2023

Horseback Riding-Related Injuries in Portugal and Prevention Strategies.

Journal: Journal of sport rehabilitation

Published: March 13, 2022

Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.

Journal: Ageing research reviews

Published: August 03, 2021

A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration.

Journal: International journal of pharmaceutics

Published: August 26, 2020

Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma.

Journal: Journal of pharmaceutical and biomedical analysis

Published: December 16, 2019

QbD-driven development of intranasal lipid nanoparticles for depression treatment.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: December 01, 2019